ateral Flow Assay for Detection of Through Tumor Necrosis Factor Alpha (Infliximab) levels
Completed
- Conditions
- Crohn's disease10017969
- Registration Number
- NL-OMON32551
- Lead Sponsor
- niversitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Crohn's disease, infliximab therapy
Exclusion Criteria
None
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method